We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Stay Invested in Primerica (PRI) Stock
Read MoreHide Full Article
Primerica's (PRI - Free Report) compelling portfolio, strong market presence, sturdy distribution channel and solid capital position poise it well for growth. These, coupled with optimistic growth projections, make it worth retaining in one’s portfolio.
Shares of this Zacks Rank #3 (Hold) company have rallied 7.9% year to date, outperforming 1.7%, 0.4% and 7.6% growth of the industry, the Finance sector and the Zacks S&P 500 composite, respectively, in the same period. It has a VGM Score of B.
The Zacks Consensus Estimate for 2024 earnings has moved 1 cent north in the past seven days, reflecting analysts’ optimism. Primerica envisions being a successful senior health business while continuing to enhance its shareholders’ value.
The Zacks Consensus Estimate for Primerica’s 2024 earnings is pegged at $17.76 per share, indicating an increase of 10.5% on 5.6% higher revenues of $3 billion. The Zacks Consensus Estimate for Primerica’s 2025 earnings is pegged at $19.51 per share, indicating an increase of 9.8% on 4.6% higher revenues of $3.1 billion. Earnings of this second-largest issuer of term-life insurance coverage in North America have risen 17.6% in the last five years, outperforming the industry average of 5.6%.
Return on equity (ROE), a profitability measure to identify how efficiently a company is utilizing its shareholders’ funds, has been improving over the last several years. PRI’s trailing 12-month ROE of 27.8% is better than the industry average of 15.4%.
Also, the return on invested capital in the trailing 12 months was 7%, better than the industry average of 0.7%, reflecting PRI’s efficiency in utilizing funds to generate income.
Image Source: Zacks Investment Research
Growth Drivers
PRI noted that 48% of middle-income Americans will not be ready for retirement based on their investment and savings habits. This is where life-licensed sales representatives will play a major role in capitalizing on the growth opportunities. Management estimates a 3% rise in sales force size in 2024.
A strong demand for protection products should drive sales growth and policy persistency. A strong business model makes the company well-poised to cater to the middle market's increased demand for financial security.
Banking on premiums from new sales, PRI estimates adjusted direct premiums to grow 5% to 6% in 2024 at the Term Life segment. Demand should continue to remain strong on the back of its insurance products launched in the fall of 2022.
Licensed representatives act as catalysts, contributing to the operational results of the insurer. For 2024, the insurer estimates a 3-5% rise in the number of Term Life policies and a 5% rise in Investment and Savings Products sales.
Life insurers are direct beneficiaries of an improving interest rate environment. An improved interest rate environment should aid net investment income.
Apart from having solid liquidity, Primerica has been strengthening its balance sheet by improving its leverage ratio. It scores strongly with credit rating agencies.
Management believes that its solid Term-life insurance business ensures consistent free cash flow. Banking on this strength, the board recently approved a $425 million buyback program through next year. This apart, it has been hiking dividends every year since 2010. Dividends increased at a five-year CAGR of 17.1%. Notably, its free cash flow conversion has remained more than 100% over the last many quarters, reflecting its solid earnings.
Stocks to Consider
Some better-ranked stocks from the insurance industry are Employers Holdings (EIG - Free Report) , Reinsurance Group of America (RGA - Free Report) and Manulife Financial Corporation (MFC - Free Report) .
Employers Holdings beat estimates in the last four quarters. The stock has gained 8.5% year to date. The Zacks Consensus Estimate for EIG’s 2024 and 2025 earnings has moved 6.6% and 8.8% north, respectively, in the past 60 days. It sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Reinsurance Group delivered a four-quarter average earnings surprise of 24.39%. The stock has gained 12.9% year to date. The Zacks Consensus Estimate for RGA’s 2024 and 2025 earnings has moved 0.4% and 0.8% north, respectively, in the past seven days. It carries a Zacks Rank #2 (Buy).
Manulife delivered a four-quarter average earnings surprise of 7.01%. The stock has gained 4.7% year to date. The Zacks Consensus Estimate for MFC’s 2024 and 2025 earnings suggests growth of 5.5% and 9.7%, respectively, from a year ago. It carries a Zacks Rank #2.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Here's Why You Should Stay Invested in Primerica (PRI) Stock
Primerica's (PRI - Free Report) compelling portfolio, strong market presence, sturdy distribution channel and solid capital position poise it well for growth. These, coupled with optimistic growth projections, make it worth retaining in one’s portfolio.
Shares of this Zacks Rank #3 (Hold) company have rallied 7.9% year to date, outperforming 1.7%, 0.4% and 7.6% growth of the industry, the Finance sector and the Zacks S&P 500 composite, respectively, in the same period. It has a VGM Score of B.
The Zacks Consensus Estimate for 2024 earnings has moved 1 cent north in the past seven days, reflecting analysts’ optimism. Primerica envisions being a successful senior health business while continuing to enhance its shareholders’ value.
The Zacks Consensus Estimate for Primerica’s 2024 earnings is pegged at $17.76 per share, indicating an increase of 10.5% on 5.6% higher revenues of $3 billion. The Zacks Consensus Estimate for Primerica’s 2025 earnings is pegged at $19.51 per share, indicating an increase of 9.8% on 4.6% higher revenues of $3.1 billion. Earnings of this second-largest issuer of term-life insurance coverage in North America have risen 17.6% in the last five years, outperforming the industry average of 5.6%.
Return on equity (ROE), a profitability measure to identify how efficiently a company is utilizing its shareholders’ funds, has been improving over the last several years. PRI’s trailing 12-month ROE of 27.8% is better than the industry average of 15.4%.
Also, the return on invested capital in the trailing 12 months was 7%, better than the industry average of 0.7%, reflecting PRI’s efficiency in utilizing funds to generate income.
Image Source: Zacks Investment Research
Growth Drivers
PRI noted that 48% of middle-income Americans will not be ready for retirement based on their investment and savings habits. This is where life-licensed sales representatives will play a major role in capitalizing on the growth opportunities. Management estimates a 3% rise in sales force size in 2024.
A strong demand for protection products should drive sales growth and policy persistency. A strong business model makes the company well-poised to cater to the middle market's increased demand for financial security.
Banking on premiums from new sales, PRI estimates adjusted direct premiums to grow 5% to 6% in 2024 at the Term Life segment. Demand should continue to remain strong on the back of its insurance products launched in the fall of 2022.
Licensed representatives act as catalysts, contributing to the operational results of the insurer. For 2024, the insurer estimates a 3-5% rise in the number of Term Life policies and a 5% rise in Investment and Savings Products sales.
Life insurers are direct beneficiaries of an improving interest rate environment. An improved interest rate environment should aid net investment income.
Apart from having solid liquidity, Primerica has been strengthening its balance sheet by improving its leverage ratio. It scores strongly with credit rating agencies.
Management believes that its solid Term-life insurance business ensures consistent free cash flow. Banking on this strength, the board recently approved a $425 million buyback program through next year. This apart, it has been hiking dividends every year since 2010. Dividends increased at a five-year CAGR of 17.1%. Notably, its free cash flow conversion has remained more than 100% over the last many quarters, reflecting its solid earnings.
Stocks to Consider
Some better-ranked stocks from the insurance industry are Employers Holdings (EIG - Free Report) , Reinsurance Group of America (RGA - Free Report) and Manulife Financial Corporation (MFC - Free Report) .
Employers Holdings beat estimates in the last four quarters. The stock has gained 8.5% year to date. The Zacks Consensus Estimate for EIG’s 2024 and 2025 earnings has moved 6.6% and 8.8% north, respectively, in the past 60 days. It sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Reinsurance Group delivered a four-quarter average earnings surprise of 24.39%. The stock has gained 12.9% year to date. The Zacks Consensus Estimate for RGA’s 2024 and 2025 earnings has moved 0.4% and 0.8% north, respectively, in the past seven days. It carries a Zacks Rank #2 (Buy).
Manulife delivered a four-quarter average earnings surprise of 7.01%. The stock has gained 4.7% year to date. The Zacks Consensus Estimate for MFC’s 2024 and 2025 earnings suggests growth of 5.5% and 9.7%, respectively, from a year ago. It carries a Zacks Rank #2.